NCT01933893

Brief Summary

Pipelle was found to increase pregnancy and implantation rates in women undergoing IVF treatment in general, and in particular in repeated implantation failure (RIF). However, there is virtually no data regarding the optimal timing for the pipelle. The current study aims to compare between follicular and luteal pipelle on pregnancy rate in RIF patients.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 29, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 2, 2013

Completed
29 days until next milestone

Study Start

First participant enrolled

October 1, 2013

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
Last Updated

September 2, 2013

Status Verified

August 1, 2013

Enrollment Period

7 months

First QC Date

August 29, 2013

Last Update Submit

August 29, 2013

Conditions

Repeated Implantation Failure

Keywords

Pipelle, luteal, follicular, implantation

Outcome Measures

Primary Outcomes (1)

  • Pregnancy rate

    April, 2014

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Women diagnosed with repeated implantation failure (RIF) who are undergoing IVF treatment.

You may qualify if:

  • Women diagnosed with RIF who are going to start a new IVF treatment

You may not qualify if:

  • Known hydrosalpinx body mass index (BMI) \>29 kg/m2 or \<18 kg/m2 Low ovarian response

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Ido Ben-Ami, MD, PhD

    Assaf Harofeh Medical Center, Zerifin, Israel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2013

First Posted

September 2, 2013

Study Start

October 1, 2013

Primary Completion

May 1, 2014

Last Updated

September 2, 2013

Record last verified: 2013-08